Skip to content
Research/Longevity Anti Aging/BAM15

BAM15

Novel mitochondrial protonophore uncoupler. Reverses diet-induced obesity in mice without affecting food intake or lean mass. More potent and selective than DNP.

Intelligence Profile

Science

Mechanism of Action

BAM15 functions as a mitochondrial uncoupler, disrupting the normal process of ATP (energy) production in cells at the molecular level. Here's how it works:

Primary Mechanism: Mitochondrial Uncoupling

BAM15 acts as a protonophore, allowing protons to bypass the normal ATP synthesis pathway in mitochondria. Under normal conditions, mitochondria create energy by building up a proton gradient across the inner mitochondrial membrane, which drives ATP production. BAM15 disrupts this process by providing an alternative pathway for protons to cross the membrane without generating ATP, causing energy to be released as heat instead.

Structural Basis

Research on the structure-activity relationship of compounds similar to BAM15 shows that N-substituted 8-trifluoromethyl-9H-purin-6-amines function as mitochondrial protonophores, providing insight into how BAM15's chemical structure enables its uncoupling activity.

Cellular Effects

The mitochondrial uncoupling induced by BAM15 leads to several downstream effects:

  • Metabolic disruption: Studies show BAM15 impairs energy metabolism, as demonstrated in research on mollusks where it caused significant metabolic dysfunction
  • Oxidative stress induction: The uncoupling process generates oxidative stress in cells
  • Tissue-level impacts: The metabolic disruption can lead to broader tissue damage when used at higher concentrations

Protective Applications

Interestingly, at lower doses, BAM15's mitochondrial effects may be protective in certain contexts:

  • Research suggests it can stabilize mitochondrial homeostasis in human sperm during cryopreservation
  • Studies indicate it may improve oocyte quality in obesity models through PPARγ-dependent mitochondrial function regulation

Evidence Limitations

While multiple studies demonstrate BAM15's mitochondrial uncoupling activity, most research is preclinical. The clinical evidence is limited, with one completed Phase 2 trial studying immune system proteins in COVID-19 patients, though the specific role of BAM15 in this context is not detailed in the available evidence.

This information is for educational purposes only and should not be considered medical advice. Consult healthcare professionals for medical guidance.